May 2004 - Volume 19 - Issue 3 : International Clinical Psychopharmacology

Secondary Logo

Journal Logo

May 2004 - Volume 19 - Issue 3
pp: 113-190

Relationships among daily dose of perospirone, concentrations of unchanged perospirone and active metabolite ID15036, anti-D2 activity, anti-5-HT2A activity and anti-5-HT2A activity/anti-D2 activity (S/D) ratio in plasma

Miyake, N.; Morokawa, Y.; Sekiguchi, G.; More

International Clinical Psychopharmacology. 19(3):181, May 2004.

A comparative prospective investigation of the efficacy and safety of the atypical antipsychotics in the treatment of schizophrenia: monotherapy by olanzapine, perospirone, quetiapine or risperidone compared with the old-style therapy by conventional antipsychotics

Shirae, Hideko; Maru, Kanae; Uemura, Tomihiko; More

International Clinical Psychopharmacology. 19(3):184, May 2004.